Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Hepatology

• Publication date

  1993-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8278(05)80212-0PMID 8315260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.

  2008cited by this paper
• Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection

  1993cited by this paper
• A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

  1990cited by this paper
• A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.

  1990cited by this paper
• Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon

  1990cited by this paper
• β- and γ-Interferon in Chronic Active Hepatitis B: A Pilot Trial of Short-Term Combination Therapy

  1989cited by this paper
• Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy.

  1989cited by this paper
• Which patients with chronic hepatitis B virus infection will respond to α‐interferon therapy? A statistical analysis of predictive factors

  1989cited by this paper
• Antiviral effect of recombinant gamma interferon in chronic hepatitis B virus infection: a pilot study.

  1988cited by this paper
• Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.

  1988cited by this paper
• Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.

  1986cited by this paper
• The interferon system in acute and chronic viral hepatitis.

  1986cited by this paper
• Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.

  1985cited by this paper
• Neutralization of Interferon by Antibody: Appraisals of Methods of Determining and Expressing the Neutralization Titer

  1984cited by this paper
• Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

  1984cited by this paper
• Viral hepatitis and liver disease

  1984cited by this paper
• An assay for the detection of the dna genome of hepatitis b virus in serum

  1982cited by this paper
• Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.

  1982cited by this paper
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

  1981cited by this paper
• Interferon in chronic hepatitis B infection.

  1980cited by this paper

• Early application of IFNγ mediated the persistence of HBV in an HBV mouse model.

  2024cites this paper
• IFN-γ: A Crucial Player in the Fight Against HBV Infection?

  2023cites this paper
• Emerging pipeline drugs for hepatitis B infection

  2011influential citation
• Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant

  2010cites this paper
• Novel approaches towards conquering hepatitis B virus infection.

  2007cites this paper
• Current therapy of chronic hepatitis B.

  2007cites this paper
• Novel Approaches to New Therapies for Hepatitis B Virus Infection

  2006cites this paper
• Interferon gamma‐1b for the treatment of fibrosis in chronic hepatitis C infection

  2006cites this paper
• Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.

  2006cites this paper
• Successful Treatment With Novel Triple Drug Combination Consisting of Interferon-γ, Interferon Alfacon-1, and Ribavirin in a Nonresponder HCV Patient to Pegylated Interferon Therapy

  2006cites this paper
• Host factors and failure of interferon-alpha treatment in hepatitis C virus.

  2004cites this paper
• Host factors and failure of interferon‐α treatment in hepatitis C virus

  2004cites this paper
• Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes.

  2001cites this paper
• Combination Chemotherapy for Hepatitis B Virus

  2000cites this paper
• Combination chemotherapy for hepatitis B virus: the path forward?

  2000cites this paper
• Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.

  1998cites this paper
• REVIEW: Present and future directions in the treatment of chronic hepatitis B infection

  1997cites this paper
• A pilot study of natural interferon γ therapy for chronic hepatitis C

  1997cites this paper
• Interferon gamma production in whole peripheral blood culture in acute hepatitis B.

  1996cites this paper
• Recent developments in the treatment of chronic hepatitis B virus infection

  1995cites this paper
• Treatment of chronic hepatitis B

  1994cites this paper